NCT07814417
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07814417
Title A Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C Mutation
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35233 United States Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
AdventHealth Orlando Orlando Florida 32803 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
START Astera, LLC East Brunswick New Jersey 08816 United States Details
Texas Oncology - Central South Austin Texas 78745 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Inova Health Care Services Falls Church Virginia 22042 United States Details
University of Wisconsin - Carbone Cancer Center Madison Wisconsin 53792 United States Details
Beijing Cancer hospital Beijing 100142 China Details
Hospital del Mar Barcelona 08003 Spain Details
Hospital Universitari Quiron Dexeus Barcelona Barcelona 08028 Spain Details
Hospital Universitario Vall d'Hebron Barcelona 08035 Spain Details
Complejo hospitalario de Jaen Jaén 23007 Spain Details
Clinica Universidad de Navarra - Madrid Madrid 28027 Spain Details
Hospital Universitario de Canarias Santa Cruz de Tenerife 38320 Spain Details
Hospital Universitario Marques De Valdecilla Santander 39008 Spain Details
Hospital Clinico Universitario de Santiago Santiago de Compostela 15706 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field